Heart failure & cardiomyopathies

1. Eur J Heart Fail8 Apr 2026

   Effects of finerenone across a range of heart failure duration: a prespecified analysis of the FINEARTS-HF trial

   Secondary analysis

2. Eur J Heart Fail8 Apr 2026

   Kidney failure risk equation and risk of kidney and cardiovascular outcomes in patients with heart failure with reduced ejection fraction: insights from PARADIGM-HF

   Secondary analysis

3. Eur J Heart Fail8 Apr 2026

   Spironolactone, early acute eGFR changes, and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from TOPCAT Americas

   Secondary analysis

4. Europace7 Apr 2026

   Temporal trends in the primary prevention of implantable cardioverter-defibrillator selection and long-term outcomes in patients with non-ischaemic dilated cardiomyopathy and ischaemic cardiomyopathy

   Cohort study

5. Circulation7 Apr 2026

   Multiorgan Physiological Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure With Preserved Ejection Fraction

   Cohort study

6. Circ Heart Fail7 Apr 2026

   Incidence, Timing and Clinical Significance of Immune-Mediated Myocardial Injury and Myocarditis After Gene Replacement Therapy: A Systematic Review and Meta-Analysis

   Meta-analysis

7. Eur J Heart Fail7 Apr 2026

   AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: rationale and study design of the GenePHIT trial

   Trial design

8. Eur Heart J7 Apr 2026

   Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact

   Cohort study

9. ESC Heart Fail7 Apr 2026

   CONFIDENT-HFpEF: a machine learning-based risk stratification for mortality and hospitalization using multimodal real-world data

   Cohort study

10. Eur J Heart Fail7 Apr 2026

    European Journal of Heart Failure International Expert Position Paper—Utilization, optimization, and clinical benefits of steroidal mineralocorticoid receptor antagonists in heart failure with a reduced ejection fraction

    Guideline or statement

11. ESC Heart Fail7 Apr 2026

    Invasive haemodynamic validation of an artificial intelligence echocardiographic tool for detecting heart failure with preserved ejection fraction

    Diagnostic or prognostic study

12. Eur J Heart Fail7 Apr 2026

    The global epidemiology of heart failure: a comprehensive and contemporary review

    Research article

13. Circulation6 Apr 2026

    Evaluation and Management of the Child With Acute Decompensated Heart Failure: A Scientific Statement From the American Heart Association

    Guideline or statement

14. ESC Heart Fail6 Apr 2026

    Association between functional Status and cardiac function in chronic heart failure: insights from the C-MIC II Trial

    Secondary analysis

15. Eur Heart J Acute Cardiovasc Care6 Apr 2026

    Prognostic value of QRS duration in acute myocarditis: insights from a multicentre cohort study

    Cohort study

16. Eur Heart J Qual Care Clin Outcomes6 Apr 2026

    Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography

    Cohort study

17. JACC Adv4 Apr 2026

    Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients

    Cohort study

18. Am Heart J3 Apr 2026

    Economic burden associated with systemic inflammation in patients with HFmrEF/HFpEF

    Cohort study

19. Circulation2 Apr 2026

    Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association

    Guideline or statement

20. JACC Clin Electrophysiol2 Apr 2026

    Competing Risk of Ventricular Tachyarrhythmia and Nonarrhythmic Mortality in Advanced Heart Failure: Impact of Left Ventricular Ejection Fraction

    Meta-analysis

21. Eur Heart J Cardiovasc Imaging2 Apr 2026

    MRI-derived wall thickness heterogeneity in hypertrophic cardiomyopathy and in carriers of sarcomeric gene mutations

    Diagnostic or prognostic study

22. JACC Cardiovasc Imaging1 Apr 2026

    Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype

    Diagnostic or prognostic study

23. JACC Adv1 Apr 2026

    Sex Differences in Age-Associated Concentric Remodeling and Diastolic Dysfunction

    Cohort study

24. Eur Heart J1 Apr 2026

    Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription

    Cohort study

25. Circulation1 Apr 2026

    Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study

    Cohort study

26. Heart Rhythm1 Apr 2026

    Improving transthyretin cardiac amyloidosis detection from electrocardiograms through the Willem artificial intelligence platform

    Cohort study

27. ESC Heart Fail1 Apr 2026

    Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)

    Trial design

28. JAMA Cardiol1 Apr 2026

    Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial

    Randomised controlled trial

29. JAMA Cardiol1 Apr 2026

    Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure: The HeartSync-LBBP Randomized Clinical Trial

    Randomised controlled trial

30. JAMA Intern Med1 Apr 2026

    Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

    Secondary analysis

31. ESC Heart Fail31 Mar 2026

    Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction

    Meta-analysis

32. Circulation31 Mar 2026

    MR-proADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis

    Diagnostic or prognostic study

33. Nat Med30 Mar 2026

    The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial

    Randomised controlled trial

34. Circulation30 Mar 2026

    Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Noninferiority Randomized Trial

    Randomised controlled trial

35. Eur Heart J Qual Care Clin Outcomes30 Mar 2026

    Association of GLP-1 receptor agonists versus bariatric surgery with outcomes in obese patients with hypertrophic cardiomyopathy: a multicenter propensity-matched analysis

    Research article

36. ESC Heart Fail30 Mar 2026

    Global burden of heart failure attributable to atrial fibrillation and flutter, insights from GBD 2021

    Cohort study

37. Eur Heart J Cardiovasc Pharmacother30 Mar 2026

    Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes

    Cohort study

38. Eur J Heart Fail30 Mar 2026

    Insights into the renin–angiotensin–aldosterone system in transthyretin amyloid cardiomyopathy

    Cohort study

39. JACC Heart Fail29 Mar 2026

    Excess and Dysfunctional Fat as a Primary Driver of Heart Failure With Preserved Ejection Fraction: From Institutional Recognition to Clinical Integration

    Research article

40. Circulation29 Mar 2026

    Sotatercept for Combined Post- and Precapillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

    Randomised controlled trial

All 1,928 Briefs in ExploreShowing Briefs 521–560 of 1,928, newest first